Dr. James Baker discusses the development of a new vaccine against anthrax that could be absorbed through the nasal mucosa with host Dr. Maurice Pickard. Dr. Baker also explains that the unique utilization of nanoemulsions toward the design of this vaccine may also apply to the development of other vaccines.
A New Weapon Against Bioterrorism
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. James Baker discusses the development of a new vaccine against anthrax that could be absorbed through the nasal mucosa with host Dr. Maurice Pickard. Dr. Baker also explains that the unique utilization of nanoemulsions toward the design of this vaccine may also apply to the development of other vaccines.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Diagnosis and Management of Metastatic PDAC
HF Management for Patients with Comorbid Conditions
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Second-line Chemotherapy Options in Metastatic PDAC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?